Shingles Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles
Condition:   Herpes Zoster Interventions:   Biological: Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A);   Drug: Placebo Sponsor:   GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2019 Category: Research Source Type: clinical trials

Systems Biology of Zoster Vaccine
Conditions:   Zoster;   Zoster Varicella;   Shingles;   Chicken Pox Intervention:   Biological: Shingrix® Sponsors:   Emory University;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2019 Category: Research Source Type: clinical trials